INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "TREATMENT OF CHRONIC KIDNEY DISEASE"

GENEVA, Sept. 9 -- ASTRAZENECA AB (SE-151-85Sodertalje) filed a patent application (PCT/IB2025/052115) for "TREATMENT OF CHRONIC KIDNEY DISEASE" on Feb 27, 2025. With publication no. WO/2025/181717, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FERRARI, Nicola (c/o AstraZeneca UK Limited1 Francis Crick Ave., Cambridge Biomedical CampusCambridge Cambridgeshire CB2 0AA), LINDHOLM, Catharina (c/o AstraZeneca ABSE-151 85Sodertalje), WOOLLARD, Kevin (c/o MedImmune Limited1 Francis Crick AvenueCambridge Biomedical CampusCambr...